Timeline
Fernando Arenzana-Seisdedos
Permanent Researcher
22 Jul 2022
publication
Tracking receptor motions at the plasma membrane reveals distinct effects of ligands on CCR5 dynamics depending on its dimerization status.
Read more18 Sep 2019
publication
Defective angiogenesis in CXCL12 mutant mice impairs skeletal muscle regeneration
Read more20 Feb 2017
publication
Suramin interacts with the positively charged region surrounding the 5-fold axis of the EV-A71 capsid and inhibits multiple enterovirus A
Read more13 Feb 2017
publication
Essential role of immobilized chemokine CXCL12 in the regulation of the humoral immune response
Read more01 Nov 2016
publication
Heparan sulfate differentially controls CXCL12α- and CXCL12γ-mediated cell migration through differential presentation to their receptor CXCR4
Read more25 Apr 2016
12 Feb 2016
09 Feb 2016
publication
Vaccine and Wild-Type Strains of Yellow Fever Virus Engage Distinct Entry Mechanisms and Differentially Stimulate Antiviral Immune Responses.
Read more23 Nov 2015
project
THE KEY ROLE OF CXCL12/SDF1 CHEMOKINE IN THE ANGIOGENESIS/MYOGENESIS COUPLING DURING MUSCLE REGENERATION
Read more03 Jul 2015
18 Jun 2015
publication
A single-residue change in the HIV-1 V3 loop associated with maraviroc resistance impairs CCR5 binding affinity while increasing replicative capacity
Read more05 Jun 2015
03 Sep 2014
publication
The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection-suramin inhibits EV71 infection in vitro and in vivo
Read more22 May 2014
publication
Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entry
Read more03 Oct 2012
publication
Homeostatic and tissue reparation defaults in mice carrying selective genetic invalidation of CXCL12/proteoglycan interactions
Read more26 Jan 2012
16 Dec 2010
publication
A pivotal role for CXCL12 signaling in HPV-mediated transformation of keratinocytes: clues to understanding HPV-pathogenesis in WHIM syndrome
Read more30 Nov 2010
publication
New insights into the mechanisms whereby low molecular weight CCR5 ligands inhibit HIV-1 infection
Read more15 Feb 2010
publication
Type I IFN controls chikungunya virus via its action on nonhematopoietic cells.
Read more28 Dec 2009
publication
Idiopathic CD4+ T-cell lymphocytopenia is associated with impaired membrane expression of the chemokine receptor CXCR4
Read more06 Sep 2009
publication
A synthetic CD4-heparan sulfate glycoconjugate inhibits CCR5 and CXCR4 HIV-1 attachment and entry
Read more24 Apr 2008
publication
CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome
Read more01 Oct 2007
publication
Long oligonucleotide microarrays for African green monkey gene expression profile analysis.
Read more01 Jun 2007
15 Sep 2006
publication
Genetics of resistance to HIV infection: Role of co-receptors and co-receptor ligands
Read more01 Mar 2006
publication
Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells
Read more17 Aug 2005
publication
The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes
Read more26 Apr 2005
publication
Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals
Read more09 Nov 2004
publication
WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12
Read more27 May 2004
publication
C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles
Read more15 Apr 2003
publication
Role of the alpha-chemokine stromal cell-derived factor (SDF-1) in the developing and mature central nervous system
Read more27 Feb 2003
publication
DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2
Read more01 Feb 2003
publication
G protein-dependent CCR5 signaling is not required for efficient infection of primary T lymphocytes and macrophages by R5 human immunodeficiency virus type 1 isolates
Read more22 Nov 2002
publication
Low levels of co-receptor CCR5 are sufficient to permit HIV envelope-mediated fusion with resting CD4 T cells
Read more12 Nov 2002
publication